In the latest episode of Med Tech Talks, Robert Klupacs is joined by Professor Andrew Wilks and Dr Chris Burns.

Professor Wilks and Dr Burns are two research leaders who were involved in the incredible breakthrough of the drug, Momelotinib, which has emerged as a treatment for myelofibrosis – a rare type of bone marrow cancer.

In this episode you will hear about:

• The journey of momelotinib from bench top to a commercial product
• Professor Wilks and Dr Burns' experience as entrepreneurs
• Where momelotinib is today and the legacy of the Australian research effort.

More information:

Learn more about Professor Andrew Wilks
 
Find out more about Dr Chris Burns

Updated version 05/08/22